BIOMED CITY WELCOMES NEW CANCER RESEARCH INSTITUTE


While Adelaide has long been regarded a key destination for medical conferences, the city’s reputation as a global medical hub has flourished with the arrival of BioMed City. The University of South Australia’s Cancer Research Institute recently joined the precinct, with SAHMRI 2, featuring the Southern Hemisphere’s first proton therapy unit, set to follow in 2022.

Introducing the Cancer Research Institute: A Leading Light in Cancer Research

Following three years of development, the University of South Australia’s $247M Cancer Research Institute officially opened in May, reinforcing Adelaide’s position as a leading light in cancer research. Located immediately adjacent to the Convention Centre’s West Building, the new Institute is home to the largest group of cancer researchers ever assembled in South Australia, offering a number of new cancer research, teaching and community engagement opportunities.

The building focuses on four key areas of cancer research, including:

  • The Centre for Cancer Biology;
  • The Centre for Drug Discovery & Development;
  • Pharmacy and Medical Sciences; and,
  • Experimental Therapeutics, Mechanisms in Cell Biology and Diseases, Bone Growth and Repair, and Psychosocial Oncology research groups.

In addition, the building houses the university’s technology-based business incubation hub along with MOD, a futuristic museum of discovery that is open to the public and features exhibitions focused on the “intersection between science, creativity, art and innovation”.

 

SAHMRI 2 to Join BioMed Precinct in 2022

Described as the ‘innovative future of healthcare’, the $300M SAHMRI 2 is set to join BioMed City in 2022.  The new development, which will rise 14 storeys next to the existing SAHMRI building, is set to house more than 400 researchers. It will be home to the Australian Bragg Centre for Proton Therapy and Research—the Southern Hemisphere’s first proton therapy unit, capable of killing inoperable cancers. The Bragg Centre is expected to treat up to 800 people a year. In addition to supporting patients and their families, SAHMRI 2 is also expected to draw leading international researchers to the city, further strengthening Adelaide’s reputation as a cutting-edge medical destination.

“This is a game-changer for patients and will put South Australia on the global stage for cancer treatment,” says Professor Steve Wesselingh, Executive Director, SAHMRI of the new development.

Simon Burgess, General Manager, Adelaide Convention Centre adds, “While medical-related events have been a core part of our business for some time, the arrival of BioMed City has certainly made our city an even more attractive proposition for medical industry events with its ready supply of speakers, delegates and students. BioMed City has reinforced Adelaide’s position on the global stage when it comes to health research and practice; the arrival of SAHMRI 2 will be another coup for our city.”